TP53 and adenocarcinoma: The collection of these clinical data suggested the germline TP53:c.640C>T is likely a deleterious variant in this patient, involved in LFS (Table 2).This prompted a follow-up for the patient with LFS management guidelines including a colonoscopy which revealed a stage IIIb adenocarcinoma of the ascending colon.